Meghmani Organics share price today

Meghmani Organics Ltd's share price was ₹55.66 at the close on 4 November 2026. It has been rising for 3 weeks. That is 4.3% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹39 and ₹75, and at that close it sat 46% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Meghmani Organics Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running.

Over the last 5.2 years the share price moved −41% while the NIFTY 500 moved +55%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: best operating margin in 15 quarters and highest quarterly profit in 13 quarters.

1. Best operating margin in 15 quarters

   Operating margin was 18% in the June 2026 quarter, against 11% a year earlier.

   From the earnings call on 28 Sep 2026.

2. Highest quarterly profit in 13 quarters

   Profit of ₹48 crore in the June 2026 quarter is the highest of the last 13 quarters.

For April to June 2026 (the quarter ended 30 June 2026), Meghmani Organics reported revenue of ₹543 crore, down 11.6% from ₹614 crore a year earlier, and a profit of ₹48.0 crore, up 269.2% from ₹13.0 crore.

Meghmani Organics results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Meghmani Organics' management discussed these results on a call held on 28 September 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Meghmani Organics closed at ₹55.66 on 4 November 2026, down 25.4% from ₹74.57 a year earlier (7 November 2025) and down 46.4% over five years. Its highest weekly close since August 2021 was ₹139.15 on 22 July 2022.

Meghmani Organics share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

277 weekly closes from 20 August 2021 to 4 November 2026.

4 Nov 2026: Meghmani Organics closed at ₹55.66, up 5.7% on the week and up 1.0% on the month. 28 Sep 2026: Meghmani Organics held its results call for April to June 2026. Management guided: Consolidated and Crop Protection topline growth in double digits over the next 3-5 years; technical/formulation mix planned toward 50:50 from 60:40.

Earlier

• Results for April to June 2026: Revenue down 11.6% and profit up 269.2% on a year earlier.

Meghmani Organics paid no dividend in the 12 months to 5 November 2026. The last was a dividend of ₹1.40 a share, ex-date 20 June 2023.

Meghmani Organics dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Not in its latest year. Meghmani Organics Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 4 of its last 7 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 28 September 2026, Meghmani Organics' management guided: Consolidated and Crop Protection topline growth in double digits over the next 3-5 years; technical/formulation mix planned toward 50:50 from 60:40.

“We already have the capital blocks available for future growth, so for the next 1 or 2 years, we do not need any significant capex.”Ankit Patel, on the call for April to June 2026

What management guided

• No significant capital spending over the next 1-2 years; maintenance spend ₹20-30 crore annually and regulatory registration spend averages ₹10 crore.
• Pigment revenue ₹600-650 crore with operating margin 7-10%.
• Crop Nutrition operating margin approximately 20% as the segment scales.
• Consolidated term loans around ₹160 crore by 31 March 2027 and below ₹100 crore the following financial year.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 28 September 2026.

When Meghmani Organics reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Amalgamation to reach ROC effectiveness and unified reporting - check the next results packet for completion and cost-efficiency commentary.

Meghmani Organics is on 3 of our India lists: Undervalued stocks, Breakout stocks and Penny stocks.

Meghmani Organics Ltd earned ₹48.0 Cr of net profit in the Jun 2026 quarter, +269.2% on the same quarter a year earlier. Full-year FY26 profit was ₹29.0 Cr. Over 6 years profit has grown −24.0% a year on average. That is 8.8% of the quarter's revenue. The same quarter a year earlier earned ₹13.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

7 of the last 12 reported quarters were loss-making.

Meghmani Organics Ltd reported ₹543 Cr of revenue in the Jun 2026 quarter, −11.6% on the same quarter a year earlier. Over 6 years it has grown 20.8% a year on average. The last full year, FY26, came in at ₹2,174 Cr. The last four reported quarters add to ₹2,103 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹2,174 Cr, +4.5% on the year before.

Recent pace: the last four quarters grew −7.6% on average, against 20.8% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −7.8%, against +16.3% a year over the last 8 quarters (rolling over).

Meghmani Organics Ltd's operating margin was 18.0% in the Jun 2026 quarter, 7.0 percentage points higher than the same quarter a year ago. Across 7 years it has been between −1.2% and 17.0%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +7.1 percentage points on the year while gross margin changed +8.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 86% of Meghmani Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹222 Cr of operating cash against ₹29.0 Cr of profit. After ₹42.0 Cr of spending on assets, ₹180 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 86% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Meghmani Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 110 days in FY26, up from 106 days in FY21. It spent ₹378 Cr on assets over the last 3 years. Customers take 113 days to pay, and stock sits for 145 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹2,174 Cr, each day of that cycle ties up about ₹6.0 Cr, so roughly ₹655 Cr is tied up in the business at any time.

FY26: customers took 113 days to pay and stock sat for 145 days, about 4.8 months of sales sitting as stock, for a full cycle of 110 days, longer than FY21's 106.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 145 days. Customers pay about 113 days after that. Suppliers are paid at 149 days. Together that makes the 110-day cycle.

Spending on assets: ₹378 Cr over the last 3 years, against ₹319 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹87.0 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Meghmani Organics Ltd's P/E is 22.0×, in the middle of its own history: higher than 58% of past readings. Its usual P/E (the middle reading) is 13.6×, over 5.2 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Where the price move came from: over 5 years the price moved −11.7% a year; about −21.7% a year came from earnings growth and about +10.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

Meghmani Organics Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: with too little history, we say so rather than guess a direction.

The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Meghmani Organics Ltd earned a ROCE of 7% in FY26. That is up from a low of −3% in FY24. Its return on capital used (ROIC) is 8.9 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

It comes from a 1.3% net margin and 0.72× asset turnover (sales divided by assets).

Why the return is what it is (FY26): a 1.3% net margin × 0.72× asset turnover × 1.96× leverage (assets divided by equity) ≈ 1.8% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 3.1% − 12.0% = −8.9 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

The 3.1% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 1.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Meghmani Organics Ltd has total debt of ₹726 Cr against shareholder equity of ₹1,545 Cr as of Jun 2026, so its debt is 0.47× its equity. Year by year, that ratio went from 0.34 in FY22 to 0.47 in FY26. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Foreign institutions cut their stake in Meghmani Organics Ltd by 1.4 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.8% of the company. Promoters moved −0.4 points over the same period, to 49.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −1.4 points over 8 quarters, to 0.8%; Promoters: −0.4 points over 8 quarters, to 49.0%; Domestic institutions: −0.4 points over 8 quarters, to 0.0%.

Why the owners changed: foreign institutions drove it (−1.4 points). They reduced their stake.

For Meghmani Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

51.9 out of 100, rank 10 of 25 in Pesticides/Agrochemicals, with 64% of the evidence available.

Meghmani Organics Ltd scores 51.9 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 10. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 22 + 9.3 + 9.6 + 11 = 51.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Meghmani Organics ranks 10 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 51.9 out of 100.